4
MARKET OVERVIEW
Generative AI and protein models drive next-gen biologics amid biosecurity and benchmarking challenges.
53
4.2.1.1
INCREASING ADOPTION OF GENERATIVE AI AND PROTEIN FOUNDATION MODELS
4.2.1.2
RISING DEMAND FOR NEXT-GENERATION BIOLOGICS AND ENGINEERED PROTEINS
4.2.1.3
INCREASING AVAILABILITY OF PROTEIN SEQUENCE, STRUCTURE, AND EXPERIMENTAL DATASETS
LIMITED AVAILABILITY OF HIGH-QUALITY EXPERIMENTALLY
4.2.2.2
HIGH COST AND COMPLEXITY OF EXPERIMENTAL VALIDATION
4.2.3.1
EXPANSION OF AI-DESIGNED DE NOVO PROTEINS
4.2.3.2
GROWTH OF AI-ENABLED ANTIBODY DISCOVERY AND OPTIMIZATION
4.2.3.3
INCREASING DEMAND FOR PROPRIETARY PROTEIN-ENGINEERING DATASETS
4.2.4.1
BIOSECURITY AND BIOSAFETY CONCERNS
4.2.4.2
LACK OF STANDARDIZED BENCHMARKING ACROSS AI PROTEIN-ENGINEERING PLATFORMS
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
AI-driven protein engineering revolutionizes healthcare IT, reshaping competitive dynamics and investment landscapes globally.
62
5.1
INDUSTRY TRENDS IN GLOBAL AI IN PROTEIN ENGINEERING MARKET
5.2
PORTER’S FIVE FORCES ANALYSIS
5.2.1
BARGAINING POWER OF SUPPLIERS
5.2.2
BARGAINING POWER OF BUYERS
5.2.3
THREAT OF SUBSTITUTES
5.2.4
THREAT OF NEW ENTRANTS
5.2.5
INTENSITY OF COMPETITIVE RIVALRY
5.3
MACROECONOMIC INDICATORS
5.3.2
GDP TRENDS AND FORECAST
5.3.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.4.1
RESEARCH & PRODUCT DEVELOPMENT
5.4.2
DATA INPUTS & COMPUTATIONAL INFRASTRUCTURE
5.4.3
AI MODEL & PLATFORM DEVELOPMENT
5.4.4
PLATFORM DEPLOYMENT & INTEGRATION
5.4.5
MARKETING AND SALES
INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET,
INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET,
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.11
IMPACT OF 2025 US TARIFF – AI IN PROTEIN ENGINEERING MARKET
5.11.3
PRICE IMPACT ANALYSIS
5.11.4
IMPACT ON COUNTRY/REGION
5.11.5
IMPACT ON END USERS
5.11.5.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.11.5.2
ACADEMIC & RESEARCH INSTITUTES
5.11.5.3
CONTRACT RESEARCH ORGANIZATIONS
5.11.5.4
INDUSTRIAL BIOTECHNOLOGY COMPANIES
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
GENERATIVE AI FOR PROTEIN DESIGN
6.1.2
PROTEIN LANGUAGE MODELS (PLMS)
6.1.3
STRUCTURE-BASED AI FOR PROTEIN ENGINEERING
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
HIGH-PERFORMANCE COMPUTING (HPC) AND CLOUD COMPUTING
6.2.2
LABORATORY AUTOMATION AND HIGH-THROUGHPUT SCREENING
6.3
ADJACENT TECHNOLOGIES
6.3.1
COMPUTATIONAL CHEMISTRY AND MOLECULAR SIMULATION
6.3.2
BIOINFORMATICS AND BIOLOGICAL DATA ANALYTICS
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5.1
PATENT PUBLICATION TRENDS FOR AI IN PROTEIN ENGINEERING MARKET
6.5.2
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.6.1
AI-ENABLED INTELLIGENT PROTEIN DESIGN AND PREDICTION
AI-DRIVEN AUTOMATED PROTEIN ENGINEERING AND DESIGN-BUILD-
6.6.3
AI-ENABLED PERSONALIZED AND FUNCTION-SPECIFIC PROTEIN ENGINEERING
7
REGULATORY LANDSCAPE
Navigate complex global regulations with region-specific insights and compliance strategies.
88
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
7.1.2
REGULATORY FRAMEWORK
7.1.2.5
MIDDLE EAST & AFRICA
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Discover unmet needs and decision influencers shaping AI-driven protein engineering market opportunities.
99
8.2
DECISION-MAKING PROCESS
8.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5.2
END USER EXPECTATIONS
9
AI IN PROTEIN ENGINEERING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 10 Data Tables
106
9.2.1
NICHE POINT SOLUTIONS
SPECIALIZED AI PLATFORMS EXPAND PROTEIN ENGINEERING BEYOND
9.2.2
END-TO-END SOLUTIONS
9.2.2.1
INTEGRATED AI PLATFORMS ENABLE MULTI-STAGE PROTEIN ENGINEERING AND ACCELERATE CANDIDATE DEVELOPMENT
9.3.1
CONSULTING & ADVISORY SERVICES
9.3.1.1
INCREASING COMPLEXITY OF AI ADOPTION CREATES DEMAND FOR PROTEIN ENGINEERING STRATEGY AND TECHNICAL EXPERTISE
9.3.2
IMPLEMENTATION & INTEGRATION SERVICES
INTEGRATION COMPLEXITY AND DATA COMPATIBILITY SHAPE ADOPTION OF
9.3.3
TRAINING & SUPPORT SERVICES
9.3.3.1
SPECIALIZED SKILLS GAPS AND EVOLVING AI TECHNOLOGIES SUSTAIN DEMAND FOR TRAINING & SUPPORT
10
AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
116
10.2
MACHINE LEARNING & DEEP LEARNING
10.2.1
FOUNDATIONAL NEURAL ARCHITECTURES UNDERPIN MODERN PROTEIN ENGINEERING WORKFLOWS
10.3
PROTEIN LANGUAGE MODELS
10.3.1
EVOLUTION-SCALE SEQUENCE MODELS ENABLE PREDICTION AND GENERATION WITHOUT STRUCTURAL INPUTS
10.4.1
GENERATIVE MODELS MOVE ANTIBODY AND BINDER DESIGN FROM SCREENING TO PROGRAMMABLE DESIGN
10.5.1
ACCURATE COMPLEX PREDICTION SUPPORTS EPITOPE-SPECIFIC DESIGN AND AFFINITY ESTIMATION
10.6.1
ACTIVE LEARNING, BAYESIAN OPTIMIZATION, AND LAB-IN-THE-LOOP PLATFORMS COMPLEMENT CORE MODEL CLASSES
11
AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
123
11.2
NEXT-GENERATION BIOLOGICS
11.2.1
THERAPEUTIC PROTEIN ENGINEERING
11.2.1.1
AI-OPTIMIZED ANTIBODIES AND ENGINEERED PROTEINS MOVE INTO LATE-STAGE DEVELOPMENT
11.2.2
MULTISPECIFIC & BISPECIFIC PROTEIN ENGINEERING
11.2.2.1
DUAL-TARGETING FORMATS ATTRACT RECORD LICENSING INVESTMENT AS ENGINEERING PLATFORMS MATURE
11.2.3
CYTOKINE & GROWTH FACTOR ENGINEERING
11.2.3.1
REDESIGNED CYTOKINES AIM TO SEPARATE THERAPEUTIC BENEFIT FROM SYSTEMIC TOXICITY
11.2.4
PROTEIN BINDER ENGINEERING
11.2.4.1
DE NOVO BINDER DESIGN REACHES DOUBLE-DIGIT TO NEAR-COMPLETE EXPERIMENTAL HIT RATES
11.2.5
OTHER NEXT-GENERATION BIOLOGICS
11.2.5.1
ANTIBODY-DRUG CONJUGATES, SCAFFOLD FUSIONS, AND NOVEL FORMATS BROADEN ENGINEERING TOOLKITS
11.5
ANTIBODY DISCOVERY & OPTIMIZATION
11.5.1
ANTIBODY DISCOVERY
11.5.1.1
GENERATIVE DESIGN REDUCES DEPENDENCE ON IMMUNIZATION AND LIBRARY SCREENING
11.5.2
ANTIBODY AFFINITY OPTIMIZATION
11.5.2.1
COMPUTATIONAL LEAD OPTIMIZATION IMPROVES POTENCY AND DOSING CONVENIENCE
11.5.3
ANTIBODY SPECIFICITY & CROSS-REACTIVITY OPTIMIZATION
11.5.3.1
ATOMIC-LEVEL DESIGN ENABLES SELECTIVE BINDING AND CONTROLLED SPECIES CROSS-REACTIVITY
11.5.4
ANTIBODY DEVELOPABILITY OPTIMIZATION
11.5.4.1
EARLY DEVELOPABILITY SCREENING REDUCES LATE-STAGE ATTRITION RISK
11.5.5
BISPECIFIC & MULTISPECIFIC ANTIBODY ENGINEERING
11.5.5.1
MATURING FORMATS AND DESIGN PLATFORMS EXTEND BEYOND ONCOLOGY T-CELL ENGAGERS
11.5.6
OTHER ANTIBODY ENGINEERING
11.5.6.1
FC MODIFICATION, HALF-LIFE EXTENSION, AND DELIVERY FORMATS BROADEN ANTIBODY DIFFERENTIATION
11.7
DE NOVO PROTEIN DESIGN
11.8
PROTEIN STABILITY & DEVELOPABILITY OPTIMIZATION
12
AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
144
12.2.1
AI-DRIVEN ANTIBODY DESIGN AND OPTIMIZATION ACCELERATE NEXT-GENERATION BIOLOGICS DEVELOPMENT
12.3.1
AI-POWERED ENZYME ENGINEERING EXPANDS APPLICATIONS ACROSS INDUSTRIAL BIOCATALYSIS
12.4
CYTOKINES & GROWTH FACTORS
12.4.1
ADVANCING PRECISION ENGINEERING OF CYTOKINES AND GROWTH FACTORS
12.5.1
AI ADDRESSES COMPLEXITY IN PEPTIDE SEQUENCE DESIGN AND FUNCTIONAL OPTIMIZATION
12.6.1
AI IMPROVES MULTI-DOMAIN DESIGN OF FUSION PROTEINS
12.7.1
DE NOVO MINIPROTEIN DESIGN OPENS NEW OPPORTUNITIES FOR PRECISION BIOLOGICS
12.8.1
EMERGING PROTEIN MODALITIES CREATE NEW OPPORTUNITIES FOR AI-ENABLED ENGINEERING
13
AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
153
13.2.1
EXPANDING SEQUENCE AND STRUCTURE DATABASES ACCELERATE TARGET AND STARTING-POINT IDENTIFICATION
13.3.1
OPEN GENERATIVE MODELS MOVE DE NOVO DESIGN FROM PROOF OF CONCEPT TO BROAD EXPERIMENTAL VALIDATION
13.4
PROTEIN OPTIMIZATION
13.4.1
MACHINE LEARNING-GUIDED OPTIMIZATION IMPROVES AFFINITY, STABILITY, AND MANUFACTURABILITY ACROSS ITERATIVE CYCLES
13.5
PROTEIN CHARACTERIZATION
13.5.1
HIGHER-RESOLUTION STRUCTURAL AND BIOPHYSICAL ANALYSIS ANCHORS COMPUTATIONAL PREDICTIONS IN EXPERIMENTAL REALITY
13.6
EXPERIMENTAL VALIDATION
13.6.1
CLOUD LABS, PUBLIC COMPETITIONS, AND LAB-IN-THE-LOOP PLATFORMS SCALE WET-LAB TESTING
14
AI IN PROTEIN ENGINEERING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
160
14.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
14.2.1
HIGH R&D INVESTMENTS AND GROWING AI INTEGRATION ACCELERATE PROTEIN ENGINEERING ADOPTION
14.3
ACADEMIC & RESEARCH INSTITUTES
ADVANCING PROTEIN SCIENCE THROUGH AI-ENABLED RESEARCH
14.4
CONTRACT RESEARCH ORGANIZATIONS
AI HELPS CROS DIFFERENTIATE PROTEIN ENGINEERING SERVICES
14.5
INDUSTRIAL BIOTECHNOLOGY COMPANIES
AI-DRIVEN BIOCATALYST DEVELOPMENT ACCELERATES
14.6.1
EXPANSION OF AI-ENABLED PROTEIN ENGINEERING ACROSS DIVERSE APPLICATIONS TO BOOST SEGMENT
15
AI IN PROTEIN ENGINEERING MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 287 Data Tables.
167
15.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
AI-DRIVEN PROTEIN DESIGN AND STRONG BIOPHARMACEUTICAL
15.2.3.1
GOVERNMENT SUPPORT FOR AI INNOVATION AND BIOMANUFACTURING STRENGTHENS MARKET GROWTH
15.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
STRONG PHARMACEUTICAL RESEARCH BASE AND AI INNOVATION
15.3.3.1
BIOPHARMA INNOVATION AND RESEARCH COMMERCIALIZATION SUPPORT MARKET EXPANSION
15.3.4.1
REGULATORY INNOVATION AND AI-DRIVEN DRUG DISCOVERY ACCELERATE ADOPTION
15.3.5.1
PHARMACEUTICAL MANUFACTURING STRENGTH AND RESEARCH MODERNIZATION CREATE OPPORTUNITIES
15.3.6.1
STRONG PHARMACEUTICAL R&D AND BIOPHARMA ECOSYSTEM SUPPORT MARKET GROWTH
15.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
15.4.2.1
AI-DRIVEN PROTEIN ENGINEERING AND BIOLOGICS INNOVATION RESHAPE PHARMACEUTICAL DEVELOPMENT
15.4.3.1
DEMOGRAPHIC PRESSURES AND AI INNOVATION DRIVE PROTEIN ENGINEERING ADOPTION
15.4.4.1
COST-EFFICIENT INNOVATION AND BIOTECHNOLOGY EXPANSION SUPPORT GROWTH
15.4.5.1
TRANSLATIONAL RESEARCH ECOSYSTEM SUPPORTS AI-ENABLED PROTEIN ENGINEERING
BIOTECHNOLOGY EXPANSION AND AI INVESTMENTS SUPPORT
15.4.7
REST OF ASIA PACIFIC
15.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
LEADING REGIONAL PHARMACEUTICAL RESEARCH ACTIVITY SUPPORTS
PHARMACEUTICAL MANUFACTURING BASE AND GROWING R&D
15.5.4
REST OF LATIN AMERICA
15.6
MIDDLE EAST & AFRICA
15.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
15.6.2.1
HEALTHCARE TRANSFORMATION AND BIOTECHNOLOGY INVESTMENTS SUPPORT MARKET GROWTH
15.6.2.2.1
VISION 2030 INVESTMENTS ACCELERATE BIOTECHNOLOGY AND AI-ENABLED PROTEIN ENGINEERING
15.6.2.3.1
HEALTHCARE INNOVATION AND BIOTECHNOLOGY INITIATIVES SUPPORT MARKET GROWTH
15.6.2.4
OTHER GCC COUNTRIES
15.6.3.1
EXPANDING BIOTECHNOLOGY AND RESEARCH CAPABILITIES SUPPORT MARKET GROWTH
15.6.4
REST OF MIDDLE EAST & AFRICA
16
COMPETITIVE LANDSCAPE
Discover strategic insights and market dominance tactics of top players and emerging competitors.
316
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
16.3
REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
16.4
MARKET SHARE ANALYSIS, 2025
16.6
VALUATION & FINANCIAL METRICS
16.7
COMPANY EVALUATION MATRIX, KEY PLAYERS (2025)
16.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
16.7.5.1
COMPANY FOOTPRINT
16.7.5.2
REGION FOOTPRINT
16.7.5.3
OFFERING FOOTPRINT
16.7.5.4
APPLICATION FOOTPRINT
16.7.5.5
AI TOOL FOOTPRINT
16.7.5.6
END USER FOOTPRINT
16.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
16.8.1
PROGRESSIVE COMPANIES
16.8.2
RESPONSIVE COMPANIES
16.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
16.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
16.8.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
16.9
COMPETITIVE SCENARIO
16.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
338
17.1.1.1
BUSINESS OVERVIEW
17.1.1.2
PRODUCTS OFFERED
17.1.1.3
RECENT DEVELOPMENTS
17.1.1.3.1
PRODUCT ENHANCEMENTS
17.1.1.4.2
STRATEGIC CHOICES
17.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
17.1.4
NVIDIA CORPORATION
17.1.5
GENERATE:BIOMEDICINES
17.1.12
EVOLUTIONARYSCALE (BIOHUB)
17.1.16
BASECAMP RESEARCH
17.1.19
LABGENIUS LIMITED
17.2.1
ARZEDA CORPORATION
18
RESEARCH METHODOLOGY
411
18.1.1
SECONDARY RESEARCH
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
18.1.2.2
KEY DATA FROM PRIMARY SOURCES
18.1.2.3
BREAKDOWN OF PRIMARIES
18.1.2.4
INSIGHTS FROM PRIMARY EXPERTS
18.2
RESEARCH METHODOLOGY DESIGN
18.3
MARKET SIZE ESTIMATION
18.4
MARKET BREAKDOWN DATA TRIANGULATION
18.5
MARKET SHARE ESTIMATION
18.7
RESEARCH LIMITATIONS
18.7.1
METHODOLOGY-RELATED LIMITATIONS
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
TABLE 1
USD EXCHANGE RATES
TABLE 2
AI IN PROTEIN ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3
AI IN PROTEIN ENGINEERING MARKET: ROLE IN ECOSYSTEM
TABLE 4
INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET, BY OFFERING (2025)
TABLE 5
INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET, BY REGION (2025)
TABLE 6
AI IN PROTEIN ENGINEERING MARKET: KEY CONFERENCES, 2026–2027
TABLE 7
CASE 1: AI-GUIDED ENZYME OPTIMIZATION USING HISTORICAL EXPERIMENTAL DATA
TABLE 8
CASE 2: AI-GENERATED PROTEIN DESIGN FOR PRECISION GENE EDITING
TABLE 9
CASE 3: COMPUTATIONAL PROTEIN DESIGN FOR AI-DESIGNED PEPTIDE THERAPEUTIC
TABLE 10
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 11
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN PROTEIN ENGINEERING MARKET
TABLE 12
AI IN PROTEIN ENGINEERING MARKET: KEY PATENTS/PATENT APPLICATIONS
TABLE 13
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
REGULATORY SCENARIO OF NORTH AMERICA
TABLE 19
REGULATORY SCENARIO OF EUROPE
TABLE 20
REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 21
REGULATORY SCENARIO OF LATIN AMERICA
TABLE 22
REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 24
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 25
UNMET NEEDS IN AI IN PROTEIN ENGINEERING MARKET
TABLE 26
END USER EXPECTATIONS IN AI IN PROTEIN ENGINEERING MARKET
TABLE 27
AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 28
AI IN PROTEIN ENGINEERING MARKET, FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 29
AI IN PROTEIN ENGINEERING MARKET, FOR SOFTWARE/PLATFORMS, BY REGION, 2024–2031 (USD MILLION)
TABLE 30
AI IN PROTEIN ENGINEERING MARKET, FOR NICHE POINT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 31
AI IN PROTEIN ENGINEERING MARKET, FOR END-TO-END SOLUTIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 32
AI IN PROTEIN ENGINEERING MARKET, FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 33
AI IN PROTEIN ENGINEERING MARKET, FOR SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 34
AI IN PROTEIN ENGINEERING MARKET, FOR CONSULTING & ADVISORY SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 35
AI IN PROTEIN ENGINEERING MARKET, FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 36
AI IN PROTEIN ENGINEERING MARKET, FOR TRAINING & SUPPORT SERVICES, BY REGION, 2024–2031 (USD MILLION)
TABLE 37
AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 38
AI IN PROTEIN ENGINEERING MARKET FOR MACHINE LEARNING & DEEP LEARNING, BY REGION, 2024–2031 (USD MILLION)
TABLE 39
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN LANGUAGE MODELS, BY REGION, 2024–2031 (USD MILLION)
TABLE 40
AI IN PROTEIN ENGINEERING MARKET FOR GENERATIVE AI, BY REGION, 2024–2031 (USD MILLION)
TABLE 41
AI IN PROTEIN ENGINEERING MARKET FOR STRUCTURE-BASED AI, BY REGION, 2024–2031 (USD MILLION)
TABLE 42
AI IN PROTEIN ENGINEERING MARKET FOR OTHER TOOLS, BY REGION, 2024–2031 (USD MILLION)
TABLE 43
AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 44
AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 45
AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 46
AI IN PROTEIN ENGINEERING MARKET FOR THERAPEUTIC PROTEIN ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
TABLE 47
AI IN PROTEIN ENGINEERING MARKET FOR MULTISPECIFIC & BISPECIFIC PROTEIN ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
TABLE 48
AI IN PROTEIN ENGINEERING MARKET FOR CYTOKINE & GROWTH FACTOR ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
TABLE 49
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN BINDER ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
TABLE 50
AI IN PROTEIN ENGINEERING MARKET FOR OTHER NEXT-GENERATION BIOLOGICS, BY REGION, 2024–2031 (USD MILLION)
TABLE 51
AI IN PROTEIN ENGINEERING MARKET FOR MOLECULAR GLUES, BY REGION, 2024–2031 (USD MILLION)
TABLE 52
AI IN PROTEIN ENGINEERING MARKET FOR DATA GENERATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 53
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 54
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 55
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY, BY REGION, 2024–2031 (USD MILLION)
TABLE 56
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY AFFINITY OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 57
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY SPECIFICITY & CROSS-REACTIVITY OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 58
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DEVELOPABILITY OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 59
AI IN PROTEIN ENGINEERING MARKET FOR BISPECIFIC & MULTISPECIFIC ANTIBODY ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
TABLE 60
AI IN PROTEIN ENGINEERING MARKET FOR OTHER ANTIBODY ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
TABLE 61
AI IN PROTEIN ENGINEERING MARKET FOR ENZYME ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
TABLE 62
AI IN PROTEIN ENGINEERING MARKET FOR DE NOVO PROTEIN DESIGN, BY REGION, 2024–2031 (USD MILLION)
TABLE 63
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN STABILITY & DEVELOPABILITY OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 64
AI IN PROTEIN ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 65
AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 66
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 67
AI IN PROTEIN ENGINEERING MARKET FOR ENZYMES, BY REGION, 2024–2031 (USD MILLION)
TABLE 68
AI IN PROTEIN ENGINEERING MARKET FOR CYTOKINES & GROWTH FACTORS, BY REGION, 2024–2031 (USD MILLION)
TABLE 69
AI IN PROTEIN ENGINEERING MARKET FOR PEPTIDES, BY REGION, 2024–2031 (USD MILLION)
TABLE 70
AI IN PROTEIN ENGINEERING MARKET FOR FUSION PROTEINS, BY REGION, 2024–2031 (USD MILLION)
TABLE 71
AI IN PROTEIN ENGINEERING MARKET FOR MINIPROTEIN, BY REGION, 2024–2031 (USD MILLION)
TABLE 72
AI IN PROTEIN ENGINEERING MARKET FOR OTHER PROTEINS, BY REGION, 2024–2031 (USD MILLION)
TABLE 73
AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 74
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN DISCOVERY, BY REGION, 2024–2031 (USD MILLION)
TABLE 75
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN DESIGN, BY REGION, 2024–2031 (USD MILLION)
TABLE 76
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 77
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 78
AI IN PROTEIN ENGINEERING MARKET FOR EXPERIMENTAL VALIDATION, BY REGION, 2024–2031 (USD MILLION)
TABLE 79
AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 80
AI IN PROTEIN ENGINEERING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 81
AI IN PROTEIN ENGINEERING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
TABLE 82
AI IN PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024–2031 (USD MILLION)
TABLE 83
AI IN PROTEIN ENGINEERING MARKET FOR INDUSTRIAL BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
TABLE 84
AI IN PROTEIN ENGINEERING MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
TABLE 85
AI IN PROTEIN ENGINEERING MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 86
NORTH AMERICA AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 88
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 89
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 91
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 92
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 93
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 95
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 96
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 97
US: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 98
US: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 99
US: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 100
US: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 101
US: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 102
US: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103
US: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104
US: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 105
US: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 106
US: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 107
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 108
CANADA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109
CANADA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 111
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 112
CANADA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113
CANADA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 115
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 116
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 117
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 118
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 119
EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120
EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 122
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 123
EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124
EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 126
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 127
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 128
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 129
GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130
GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 132
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 133
GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134
GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 136
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 137
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 138
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 139
FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140
FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 142
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 143
FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144
FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 146
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 147
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 148
UK: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 149
UK: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 150
UK: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151
UK: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 152
UK: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 153
UK: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154
UK: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155
UK: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 156
UK: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 157
UK: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 158
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 159
ITALY: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160
ITALY: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 162
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 163
ITALY: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164
ITALY: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 166
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 167
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 168
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 169
SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 170
SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 172
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 173
SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174
SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 176
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 177
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 178
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 179
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 180
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 182
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 183
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 186
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 187
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 188
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 189
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 190
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 193
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 194
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 197
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 198
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 199
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 200
CHINA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201
CHINA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 203
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 204
CHINA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205
CHINA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 207
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 208
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 209
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 210
JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211
JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 212
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 213
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 214
JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215
JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 217
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 218
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 219
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 220
INDIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221
INDIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 223
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 224
INDIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225
INDIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 227
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 228
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 229
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 230
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 233
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 234
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 235
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 236
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 237
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 238
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 239
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 240
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 242
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 243
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 244
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 245
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 246
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 247
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 248
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 249
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 250
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 252
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 253
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 254
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 257
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 258
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 259
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 260
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 261
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 262
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 263
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 264
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 265
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 268
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 269
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 270
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 271
BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 272
BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 273
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 274
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 275
BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 276
BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 277
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 278
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 279
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 280
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 281
MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 282
MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 284
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 285
MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286
MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 288
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 289
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 290
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 291
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 294
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 295
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 298
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 299
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 300
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 301
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 302
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 303
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 304
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 305
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 306
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 308
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 309
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 310
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 311
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 312
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 313
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 314
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 315
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 316
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 317
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 318
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 319
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 320
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 321
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 322
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 323
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 324
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 325
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 326
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 327
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 328
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 329
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 330
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 331
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 332
UAE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 333
UAE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 334
UAE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 335
UAE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 336
UAE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 337
UAE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 338
UAE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 339
UAE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 340
UAE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 341
UAE: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 342
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 343
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 344
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 345
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 346
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 347
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 348
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 349
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 350
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 351
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 352
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 353
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 354
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 355
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 356
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 357
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 358
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 359
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 360
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 361
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 362
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 363
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 364
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 365
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
TABLE 366
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 367
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 368
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
TABLE 369
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
TABLE 370
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
TABLE 371
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 372
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN PROTEIN ENGINEERING MARKET, JANUARY 2023–SEPTEMBER 2026
TABLE 373
THE AI IN PROTEIN ENGINEERING MARKET: DEGREE OF COMPETITION
TABLE 374
AI IN PROTEIN ENGINEERING MARKET: REGION FOOTPRINT
TABLE 375
AI IN PROTEIN ENGINEERING MARKET: OFFERING FOOTPRINT
TABLE 376
AI IN PROTEIN ENGINEERING MARKET: APPLICATION FOOTPRINT
TABLE 377
AI IN PROTEIN ENGINEERING MARKET: AI TOOL FOOTPRINT
TABLE 378
AI IN PROTEIN ENGINEERING MARKET: END USER FOOTPRINT
TABLE 379
AI IN PROTEIN ENGINEERING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 380
AI IN PROTEIN ENGINEERING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
TABLE 381
AI IN PROTEIN ENGINEERING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY OFFERING
TABLE 382
AI IN PROTEIN ENGINEERING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023–SEPTEMBER 2026
TABLE 383
AI IN PROTEIN ENGINEERING MARKET: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 384
SCHRÖDINGER, INC.: COMPANY OVERVIEW
TABLE 385
SCHRÖDINGER, INC.: PRODUCTS OFFERED
TABLE 386
SCHRÖDINGER, INC.: PRODUCT ENHANCEMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 387
SCHRÖDINGER, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 388
XTALPI: COMPANY OVERVIEW
TABLE 389
XTALPI: PRODUCTS OFFERED
TABLE 390
XTALPI: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 391
DASSAULT SYSTÈMES: COMPANY OVERVIEW
TABLE 392
DASSAULT SYSTÈMES: PRODUCTS OFFERED
TABLE 393
DASSAULT SYSTÈMES: PRODUCT LAUNCHES/ENHANCEMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 394
DASSAULT SYSTÈMES: DEALS, JANUARY 2023– SEPTEMBER 2026
TABLE 395
NVIDIA CORPORATION: COMPANY OVERVIEW
TABLE 396
NVIDIA CORPORATION: PRODUCTS /SOLUTIONS OFFERED
TABLE 397
NVIDIA CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 398
NVIDIA CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 399
GENERATE:BIOMEDICINES: COMPANY OVERVIEW
TABLE 400
GENERATE:BIOMEDICINES: PRODUCTS OFFERED
TABLE 401
GENERATE:BIOMEDICINES: PRODUCT ENHANCEMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 402
GENERATE:BIOMEDICINES: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 403
ABSCI CORP.: COMPANY OVERVIEW
TABLE 404
ABSCI CORP.: PRODUCTS OFFERED
TABLE 405
ABSCI CORP.: DEALS, JANUARY 2023– SEPTEMBER 2026
TABLE 406
INSILICO MEDICINE: COMPANY OVERVIEW
TABLE 407
INSILICO MEDICINE: PRODUCTS /SOLUTIONS OFFERED
TABLE 408
INSILICO MEDICINE: PRODUCT LAUNCHES/ENHANCEMENT, JANUARY 2023–SEPTEMBER 2026
TABLE 409
INSILICO MEDICINE: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 410
CRADLE: COMPANY OVERVIEW
TABLE 411
CRADLE: PRODUCTS OFFERED
TABLE 412
CRADLE: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 413
CRADLE: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 414
A-ALPHA BIO, INC.: COMPANY OVERVIEW
TABLE 415
A-ALPHA BIO, INC.: PRODUCTS OFFERED
TABLE 416
A-ALPHA BIO, INC.: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 417
A-ALPHA BIO, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 418
A-ALPHA BIO, INC.: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 419
ISOMORPHIC LABS: COMPANY OVERVIEW
TABLE 420
ISOMORPHIC LABS: PRODUCTS OFFERED
TABLE 421
ISOMORPHIC LABS: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 422
ISOMORPHIC LABS: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 423
CHAI DISCOVERY: COMPANY OVERVIEW
TABLE 424
CHAI DISCOVERY: PRODUCTS OFFERED
TABLE 425
CHAI DISCOVERY: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–SEPTEMBER 2026
TABLE 426
CHAI DISCOVERY: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 427
CHAI DISCOVERY: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 428
EVOLUTIONARYSCALE (BIOHUB): COMPANY OVERVIEW
TABLE 429
EVOLUTIONARYSCALE (BIOHUB): PRODUCTS OFFERED
TABLE 430
EVOLUTIONARYSCALE (BIOHUB): PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–SEPTEMBER 2026
TABLE 431
EVOLUTIONARYSCALE (BIOHUB): DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 432
EVOLUTIONARYSCALE (BIOHUB): OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 433
PROFLUENT: COMPANY OVERVIEW
TABLE 434
PROFLUENT: PRODUCTS OFFERED
TABLE 435
PROFLUENT: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 436
PROFLUENT: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 437
BIGHAT BIO: COMPANY OVERVIEW
TABLE 438
BIGHAT BIO: PRODUCTS OFFERED
TABLE 439
BIGHAT BIO: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 440
BIGHAT BIO: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 441
LATENT LABS: COMPANY OVERVIEW
TABLE 442
LATENT LABS: PRODUCTS OFFERED
TABLE 443
LATENT LABS: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 444
LATENT LABS: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 445
LATENT LABS: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 446
BASECAMP RESEARCH: COMPANY OVERVIEW
TABLE 447
BASECAMP RESEARCH: PRODUCTS OFFERED
TABLE 448
BASECAMP RESEARCH: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 449
BASECAMP RESEARCH: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 450
BASECAMP RESEARCH: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 451
NABLA BIO, INC.: COMPANY OVERVIEW
TABLE 452
NABLA BIO, INC.: PRODUCTS OFFERED
TABLE 453
NABLA BIO, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 454
NABLA BIO, INC.: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 455
EVOZYNE: COMPANY OVERVIEW
TABLE 456
EVOZYNE: PRODUCTS OFFERED
TABLE 457
EVOZYNE: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 458
EVOZYNE: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 459
LABGENIUS LIMITED: COMPANY OVERVIEW
TABLE 460
LABGENIUS LIMITED: PRODUCTS OFFERED
TABLE 461
LABGENIUS LIMITED: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 462
LABGENIUS LIMITED: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 463
ARZEDA CORPORATION: COMPANY OVERVIEW
TABLE 464
MENTEN AI: COMPANY OVERVIEW
TABLE 465
PROTEINQURE: COMPANY OVERVIEW
TABLE 466
OUTPACE BIO: COMPANY OVERVIEW
TABLE 467
AI PROTEINS: COMPANY OVERVIEW
TABLE 468
MONODBIO: COMPANY OVERVIEW
TABLE 469
BIOMATTER INC.: COMPANY OVERVIEW
TABLE 470
DIFFUSE BIO: COMPANY OVERVIEW
TABLE 471
RISK ASSESSMENT: AI IN PROTEIN ENGINEERING MARKET
FIGURE 1
AI IN PROTEIN ENGINEERING MARKET SEGMENTATION
FIGURE 3
GLOBAL AI IN PROTEIN ENGINEERING MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN PROTEIN ENGINEERING MARKET, 2023–2026
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF AI IN PROTEIN ENGINEERING MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS IN AI IN PROTEIN ENGINEERING MARKET, 2026–2031
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN AI IN PROTEIN ENGINEERING MARKET DURING FORECAST PERIOD
FIGURE 8
INCREASING R&D INVESTMENTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE GROWTH IN AI IN PROTEIN ENGINEERING MARKET
FIGURE 9
SOFTWARE/PLATFORMS HELD MAJOR SHARE IN NORTH AMERICA IN 2025
FIGURE 10
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11
AI IN PROTEIN ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 12
AI IN PROTEIN ENGINEERING MARKET: VALUE CHAIN ANALYSIS
FIGURE 13
AI IN PROTEIN ENGINEERING MARKET: ECOSYSTEM ANALYSIS
FIGURE 14
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 16
PATENT PUBLICATION TRENDS IN AI IN PROTEIN ENGINEERING MARKET, 2015–2026
FIGURE 17
JURISDICTION AND TOP APPLICANT ANALYSIS FOR AI IN PROTEIN ENGINEERING MARKET
FIGURE 18
TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AI IN PROTEIN ENGINEERING MARKET (JANUARY 2015 TO JUNE 2026)
FIGURE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 20
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 21
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET SNAPSHOT
FIGURE 22
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET SNAPSHOT
FIGURE 23
AI IN PROTEIN ENGINEERING MARKET: REVENUE ANALYSIS OF KEY PLAYERS
FIGURE 24
AI IN PROTEIN ENGINEERING MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
FIGURE 25
AI IN PROTEIN ENGINEERING MARKET: BRAND COMPARATIVE ANALYSIS
FIGURE 26
EV/EBITDA OF KEY VENDORS
FIGURE 27
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 28
AI IN PROTEIN ENGINEERING MARKET: COMPANY EVALUATION MATRIX (2025)
FIGURE 29
AI IN PROTEIN ENGINEERING MARKET: COMPANY FOOTPRINT
FIGURE 30
AI IN PROTEIN ENGINEERING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31
SCHRÖDINGER, INC.: COMPANY SNAPSHOT (2025)
FIGURE 32
XTALPI: COMPANY SNAPSHOT (2025)
FIGURE 33
DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2025)
FIGURE 34
NVIDIA CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 35
ABSCI CORP.: COMPANY SNAPSHOT (2025)
FIGURE 36
INSILICO MEDICINE: COMPANY SNAPSHOT (2025)
FIGURE 37
RESEARCH DESIGN
FIGURE 38
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 39
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 40
BOTTOM-UP APPROACH
FIGURE 41
TOP-DOWN APPROACH
FIGURE 42
CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF AI IN PROTEIN ENGINEERING INDUSTRY
FIGURE 43
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 44
DATA TRIANGULATION METHODOLOGY
Growth opportunities and latent adjacency in AI in Protein Engineering Market